Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

In the face of the pandemic, are all equal? On the suitability of the Gini index to monitor time and geographic trends in incidence and death data during the SARS-CoV-2 pandemic

View ORCID ProfileKirsi Manz, View ORCID ProfileUlrich Mansmann
doi: https://doi.org/10.1101/2020.08.13.20174011
Kirsi Manz
1Institute of Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kirsi Manz
Ulrich Mansmann
1Institute of Medical Information Processing, Biometry, and Epidemiology, Ludwig-Maximilians University Munich, Munich, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ulrich Mansmann
  • For correspondence: mansmann@ibe.med.uni-muenchen.de
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Health inequalities across nations reinforce social and economic differences. The European Commission has outlined its commitment to reducing health inequalities. The SARS-CoV-2 pandemic is a disruptive event with global, national, and local effects on every aspect of a society’s life. Therefore, it is of interest to quantify and display health (in)equality induced by COVID-19 over time and on different geographic scales (global, continental, national, regional).

We aimed to perform a study of (in)equality regarding COVID-19 related data on infections and deaths using the Gini index (GI). A specific focus of our analysis is the (in)equality of infection fatality rates. The Gini index was developed to explore inequality in wealth within or between nations. It is a relative measure which quantifies the ratio of the mean absolute difference between non-negative numerical observations and their mean: GI=0 describes a situation where all values are equal, GI=1 corresponds to one single positive observation among all non-negative observations. We use global, nation- and statewide data to evaluate the inequality at different geographical scales. We also reflect on the suitability of the Gini index to monitor equality aspects of the pandemic.

Data from the SARS-CoV-2 pandemic show a considerable amount of inequality in the global distribution of infections and deaths. Only few countries contribute largely to the total infection and death toll. Inequality may result from heterogeneous reporting systems, heterogeneous policy making to fight the pandemic, heterogeneous health systems, and demographic structures. Inequality decreases when going from continental to national or regional levels. Time trends at national level reflect local outbreaks. There is inequality in infection fatality rates, too. Because of equality of income or wealth within a society, low GIs (≤ 0.4) are related to positive connotations like fairness and justice. In the epidemiological setting, however, a GI=1 reflects the goal striven for: The epidemic is restricted to one region while the surroundings are not affected – the epidemic has failed to spread.

We used the Gini index to reflect inequality between incidence and death rates of nations or geographic regions. The interpretation of the differences between reported GIs is not straightforward. Furthermore, combined with the information presented by maps, the GI is a useful tool.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No external funding was received for the study.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Not applicable

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • The whole manuscript was revised and the analyses now include data up to end of September 2020.

Data Availability

All datasets generated and/or analysed during the current study together with the R code are available in the OSF repository, https://osf.io/c3ren/.

https://osf.io/c3ren/

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted October 21, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
In the face of the pandemic, are all equal? On the suitability of the Gini index to monitor time and geographic trends in incidence and death data during the SARS-CoV-2 pandemic
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
In the face of the pandemic, are all equal? On the suitability of the Gini index to monitor time and geographic trends in incidence and death data during the SARS-CoV-2 pandemic
Kirsi Manz, Ulrich Mansmann
medRxiv 2020.08.13.20174011; doi: https://doi.org/10.1101/2020.08.13.20174011
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
In the face of the pandemic, are all equal? On the suitability of the Gini index to monitor time and geographic trends in incidence and death data during the SARS-CoV-2 pandemic
Kirsi Manz, Ulrich Mansmann
medRxiv 2020.08.13.20174011; doi: https://doi.org/10.1101/2020.08.13.20174011

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (452)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5268)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (699)
  • Health Policy (360)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5889)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (143)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (864)
  • Public and Global Health (2021)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)